GlassScriptPhysician profile
Elias Dakwar
NPI 1801095609
$347,709.60
in general payments reported to CMS, 2019-2025
35 companies · $67K in 2025
The $67K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $69K · 2021: $71K · 2022: $43K · 2023: $39K · 2024: $20K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $74K · Royalty Or License: $40K · Travel and Lodging: $6,948 · Food and Beverage: $5,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $73,764.40 |
| Royalty Or License | $39,599.19 |
| Travel and Lodging | $6,948.45 |
| Food and Beverage | $5,922.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $117,800.17 | 2019-2023 | Xlif, Excavation, Nuvasive |
| Stryker Corporation | $112,062.42 | 2019-2025 | Cascadia Interbody System, Tritanium, Xia 3 |
| Globus Medical, INC. | $47,635.76 | 2024-2025 | Xlif, Nts, Excelsius Gps |
| Medical Device Business Services, INC. | $28,850.20 | 2019-2025 | Expedium, Symphony, Trialtis |
| Orthofix Medical, INC. | $15,538.72 | 2025 | Lattus, Miscellaneous |
| Vb Spine LLC | $10,060.48 | 2025 | Vulcan Spinal System, Everest Spinal System |
| Surgalign Spine Technologies, INC. | $9,061.21 | 2019-2022 | |
| Xtant Medical INC | $1,533.66 | 2024-2025 | |
| Abbott Laboratories | $1,053.16 | 2023-2025 | Eterna, Proclaim |
| Depuy Synthes Products, INC. | $949.39 | 2023-2024 | |
| Depuy Synthes Sales INC. | $703.24 | 2019-2023 | Teligen, Conduit |
| Medtronic USA, INC. | $591.17 | 2019-2020 | |
| Medtronic, INC. | $575.45 | 2021-2025 | Unid_pass, Plasmablade(Tm), Mazor X System |
| Carlsmed, INC. | $330.40 | 2022-2024 | Aprevo |
| Zimmer Biomet Holdings, INC. | $132.81 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $128.72 | 2023 | Reactiv8 |
| Abbvie INC. | $126.24 | 2024-2025 | |
| Prosidyan, INC | $50.60 | 2019 | |
| Integra Lifesciences Corporation | $49.11 | 2019-2021 | |
| Surgical Theater. INC. | $49.02 | 2025 | |
| Lundbeck LLC | $48.88 | 2021-2024 | Vyepti |
| Neuropace, INC. | $47.61 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.66 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $33.88 | 2021 | |
| Baxter Healthcare | $32.54 | 2020 | |
| Relievant Medsystems, INC. | $31.59 | 2019 | |
| Cerapedics INC. | $28.93 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Eisai INC. | $25.00 | 2023 | |
| Bioventus LLC | $24.42 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Sk Life Science, INC. | $21.51 | 2021 | |
| Aquestive Therapeutics, INC. | $21.48 | 2021 | |
| Tanabe Pharma America, INC. | $20.25 | 2024 | |
| Kyowa Kirin, INC. | $18.91 | 2020 | |
| Avanir Pharmaceuticals, INC. | $16.95 | 2019 | |
| Springworks Therapeutics, INC. | $15.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elias Dakwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.